Literature DB >> 10748459

Optimal N-ethyl-N-nitrosourea (ENU) doses for inbred mouse strains.

J S Weber, A Salinger, M J Justice.   

Abstract

ENU is a powerful germline mutagen in the mouse, providing the opportunity to analyze the functions of large numbers of genes in the mammalian genome. In many mutagenesis experiments, it would be beneficial to exploit the advantages of inbred mouse strains. To perform an effective ENU mutagenesis screen using inbred mice, a dosage regimen is required to determine the optimal dose of ENU for that inbred strain, a time-consuming preliminary process. We have carried out dosage regimens for mutagenizing doses of ENU in ten inbred strains of mouse: 129X1/SvJ, 129S6/SvEv, A/J, BALB/cJ, BTBR/N, C3He/J, C3HeB/FeJ, C57BL/6J, C57BR/cdJ, and CBA/CaJ, and determined an optimal dose for each strain, defined by length of sterile period and number of males to survive treatment. Three strains: A/J, BALB/cJ and C57BL/6J, are able to tolerate high doses, up to 300 mg/kg body weight, and are highly recommended for mutagenesis studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748459

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  19 in total

1.  Focusing forward genetics: a tripartite ENU screen for neurodevelopmental mutations in the mouse.

Authors:  R W Stottmann; J L Moran; A Turbe-Doan; E Driver; M Kelley; D R Beier
Journal:  Genetics       Date:  2011-04-21       Impact factor: 4.562

Review 2.  Dissecting immunity by germline mutagenesis.

Authors:  Onjee Choi; Sophie Rutschmann
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

3.  A genetic screen for modifiers of the delta1-dependent notch signaling function in the mouse.

Authors:  Isabel Rubio-Aliaga; Dian Soewarto; Sibylle Wagner; Matthias Klaften; Helmut Fuchs; Svetoslav Kalaydjiev; Dirk H Busch; Martina Klempt; Birgit Rathkolb; Eckhard Wolf; Koichiro Abe; Stefan Zeiser; Gerhard K H Przemeck; Johannes Beckers; Martin Hrabé de Angelis
Journal:  Genetics       Date:  2006-12-18       Impact factor: 4.562

4.  Creating a "hopeful monster": mouse forward genetic screens.

Authors:  Vanessa L Horner; Tamara Caspary
Journal:  Methods Mol Biol       Date:  2011

5.  Efficient and fast targeted production of murine models based on ENU mutagenesis.

Authors:  M Augustin; R Sedlmeier; T Peters; U Huffstadt; E Kochmann; D Simon; M Schöniger; S Garke-Mayerthaler; J Laufs; M Mayhaus; S Franke; M Klose; A Graupner; M Kurzmann; C Zinser; A Wolf; M Voelkel; M Kellner; M Kilian; S Seelig; A Koppius; A Teubner; D Korthaus; M Nehls; S Wattler
Journal:  Mamm Genome       Date:  2005-06       Impact factor: 2.957

6.  An N-ethyl-N-nitrosourea mutagenesis screen for epigenetic mutations in the mouse.

Authors:  Ivona Percec; Joanne L Thorvaldsen; Robert M Plenge; Christopher J Krapp; Joseph H Nadeau; Huntington F Willard; Marisa S Bartolomei
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

7.  The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis.

Authors:  Erin L Volk; Liying Fan; Katja Schuster; Jerold E Rehg; Linda C Harris
Journal:  Mol Cancer Res       Date:  2009-06-02       Impact factor: 5.852

8.  An N-ethyl-N-nitrosourea mutagenesis recessive screen identifies two candidate regions for murine cardiomyopathy that map to chromosomes 1 and 15.

Authors:  Liliana Fernandez; Douglas A Marchuk; Jennifer L Moran; David R Beier; Howard A Rockman
Journal:  Mamm Genome       Date:  2009-04-23       Impact factor: 2.957

9.  ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease.

Authors:  Jer-Yuarn Wu; Hsiao-Jung Kao; Sing-Chung Li; Robert Stevens; Steven Hillman; David Millington; Yuan-Tsong Chen
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

10.  Sec24b selectively sorts Vangl2 to regulate planar cell polarity during neural tube closure.

Authors:  Janna Merte; Devon Jensen; Kevin Wright; Sarah Sarsfield; Yanshu Wang; Randy Schekman; David D Ginty
Journal:  Nat Cell Biol       Date:  2009-12-06       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.